LIEBMAN SEYMOUR 4
4 · T2 Biosystems, Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
LIEBMAN SEYMOUR
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-06-25−73,224→ 0 total→ Common Stock (73,224 underlying) - Exercise/Conversion
Common Stock
2022-06-25+73,224→ 235,121 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On June 25, 2021, the reporting person was granted 73,224 restricted stock units that vested on the earlier of (i) June 25, 2022, and (ii) the date of the next annual meeting of stockholders.